Skip to main content
. 2023 Aug 9;28(4):323–328. doi: 10.5863/1551-6776-28.4.323

Table 3.

Differences in Parental Perceptions of Unlicensed CBD Products Based on CBD Administration to a Child

Survey Item Uses CBD, median (IQR), n = 162 Does Not Use CBD, median (IQR), n = 356
Agreement: 1 = definitely yes, 5 = definitely not
 Do you think it is safe to use CBD products in children?* 1 (1–2) 2 (2–3)
 Are there risks associated with using CBD products in children* 3 (2–4) 3 (2–3)
 Do you believe there is enough research and evidence to help you decide what CBD products you should use for your child?* 2 (1–2) 3 (2–4)
 Do you think the CBD products available to you are well regulated by governing bodies?* 2 (1–3) 3 (2–4)
Which of the following options are most important for helping you determine a “good” quality CBD product: 1 = not at all important, 5 = extremely important
 The product is made by a well-known manufacturer/brand 4 (3–5) 4 (3–5)
 The product has been approved for US marketing 5 (3–5) 5 (4–5)
 Packaging 3 (2–4) 3 (2–4)
 Price 4 (3–5) 4 (3–5)
 Recommendation 4 (3–5) 4 (3–5)
 Dosage form (e.g., tablet, capsule, gummy, oil, vape, pen) 5 (4–5) 4 (3–5)
Rate your perceived level of support by the following people in your life for using CBD products in children in your community: 1 = fully oppose, 5 = fully support
 Family* 5 (3–5) 3 (2–5)
 Friends* 5 (4–5) 4 (3–5)
 Local community* 4 (3–5) 3 (2–4)
 Religious leaders* 3 (2–4) 3 (1–3)

CBD, cannabidiol

* p < 0.001.

p = 0.024, viewed as more important by the CBD use group upon statistical analysis despite similar median and IQR.